Reply to “Good! is it the best ???

The questions that were put forth to the patients were similar to those that were followed in the ERICA trial, i.e., patients were evaluated for average frequency of self‑reported anginal episodes during the treatment phase, changes in sublingual nitroglycerine use, heart rate, blood pressure, and adverse events.[3] Most of the patients were not taking sublingual nitroglycerine by the end of the study except two patients in the ivabradine group. Publishing questionnaire used in the study is a decision of the journal. If you want and request, we are willing to share it with you in the best interest of research.